The LDN Book: How a Little-Known Generic Drug - Low Dose Naltrexone - Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More
The latest research on how LDN may be used to treat autoimmune diseases, cancer, autism, depression, and more Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and dep... read full description below.
This title is no longer available locally, but in stock internationally – usually ships 2-3 weeks.
This title is firm sale. Please select carefully as returns are not accepted.
... view full title details below.
Full details for this title
|Library of Congress
||Naltrexone, Naltrexone - Therapeutic use, Narcotic Antagonists - therapeutic use, Naltrexone - pharmacology, Opioid Peptides - metabolism
||Family & Health: General
Description of this Book
The latest research on how LDN may be used to treat autoimmune diseases, cancer, autism, depression, and more Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? Low Dose Naltrexone explains the drug s origins, its primary mechanism, and the latest research from practicing physicians and pharmacists as compiled by Linda Elsegood of The LDN Research Trust, the world s largest LDN charity organization with over 19,000 members worldwide. Featuring ten chapters contributed by medical professionals on LDN s efficacy and two patient-friendly appendices, Low Dose Naltrexone is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.
Awards, Reviews & Star Ratings
||LowDose Naltrexone (LDN) was discovered by my husband and partner, Dr. Bernard Bihari. Incredibly informativeand superbly written by various members of the medical profession sharing their experiences using this extraordinary drug, The LDN Bookhonors his legacyin helping patients suffering from autoimmune and other diseasestoregain their health and their lives. --Jacqueline Young
Linda Elsegood is the founder of the LDN Research Trust, which was set up in the UK as a Registered Charity in 2004, and is the editor of The LDN Book. Diagnosed with MS in August of 2000, she started LDN therapy in December of 2003, and now has a better quality of life and hope for the future. Through the Trust, she has connected thousands of patients, doctors, and pharmacists around the world with information, articles, and patient stories about LDN.